Lillian Ng Email and Phone Number

Lead global patient solutions strategy for rare diseases, accelerating rare disease diagnosis worldwide.-Prioritize and lead AI/ML digital solution pilot in emerging and growth markets. Drive best practices sharing across regions to accelerate rare disease diagnois globally. -Oversee rare disease global diagnostic program utilising an In vitro Diagnostic Device (IVDR) in 40 countries, accelerating and simplifying rare disease diagnosis worldwide.-Spearheaded the expansion and… Show more Lead global patient solutions strategy for rare diseases, accelerating rare disease diagnosis worldwide.-Prioritize and lead AI/ML digital solution pilot in emerging and growth markets. Drive best practices sharing across regions to accelerate rare disease diagnois globally. -Oversee rare disease global diagnostic program utilising an In vitro Diagnostic Device (IVDR) in 40 countries, accelerating and simplifying rare disease diagnosis worldwide.-Spearheaded the expansion and launch of spotHAE using Dry Blood Spots (DBS) kits in rare disease, surpassing expectations and significantly impacting diagnostic rates on a global scale.-Led strategic assessments of rare disease solutions, gaining buy-in for long-term patient-focused strategies that showcase strategic thinking and innovation.-LED RED Community, a cross-enterprise group of internal innovators, and co-lead various functional initiatives, contributing to organizational success and talent development. Show less

Developed global patient journey and patient support strategy for HAE, PID, SID, MMN, CIDP and CMV, enhancing patient engagement and product differentiation.-Experience in developing global patient services strategy, service design and global patient journey. -Built strong collaboration with patient organizations and healthcare professionals to co-create solutions to improve health outcomes and patient experience. -Led Global Patient Expert Council to drive patient engagement… Show more Developed global patient journey and patient support strategy for HAE, PID, SID, MMN, CIDP and CMV, enhancing patient engagement and product differentiation.-Experience in developing global patient services strategy, service design and global patient journey. -Built strong collaboration with patient organizations and healthcare professionals to co-create solutions to improve health outcomes and patient experience. -Led Global Patient Expert Council to drive patient engagement and inputs on patient solutions.-Led large scale cross-functional integration activities to ensure smooth and successful functional reorganization. Show less

Led design of personalized Patient Support Programs on disease education, treatment onboarding, adherence support, transition care and travel support. Resulting in improvement in patient engagement, adherence, customer satisfaction and product differentiation.

Built a global center of excellence to provide patient services across international markets. - Defined an efficient and compliant framework to manage named patient access, a channel to meet unmet patient needs in countries where the requested products are not commercially available.- Developed a management dashboard to effectively track distributor performance and to ensure compliance.- Established a consistent business case review process for geographical expansion which was… Show more Built a global center of excellence to provide patient services across international markets. - Defined an efficient and compliant framework to manage named patient access, a channel to meet unmet patient needs in countries where the requested products are not commercially available.- Developed a management dashboard to effectively track distributor performance and to ensure compliance.- Established a consistent business case review process for geographical expansion which was implemented in all international markets across brands. Show less

Led strategic planning and program management, driving process improvements and organization restructuring and integration.- Partnered with Head of International Commerical and Program Strategy Team Leader to facilitate effective decision making and translation of strategic direction into aligned, integrated operational plans.- Managed a cross-functional transition team with senior executives, acting as primary contact to a team of external consultants, to re-structure the… Show more Led strategic planning and program management, driving process improvements and organization restructuring and integration.- Partnered with Head of International Commerical and Program Strategy Team Leader to facilitate effective decision making and translation of strategic direction into aligned, integrated operational plans.- Managed a cross-functional transition team with senior executives, acting as primary contact to a team of external consultants, to re-structure the International Commercial organization to improve efficiency and drive growth.- Acted as core Program Strategy Team member and co-lead of the Drug Development Team to manage new formulation launches and geographic expansion submissions in China and the Middle East.- Collaborated closely with Commercial and Program Resources & Decision Support function to estimate resource requirements in support of new business cases. Show less

Program managed several respiratory programs on the conduct of clinical trials, major global submissions, and life-cycle management activities. - Managed heavy-weight drug development programmes with annual budgets of more than $100 million USD. All clinical trials and submission activities in Europe, US, Japan, and China were completed ahead of aggressive targets and within budget.- Created, maintained, and monitored integrated programme plans using MS Project and Gantt Charts;… Show more Program managed several respiratory programs on the conduct of clinical trials, major global submissions, and life-cycle management activities. - Managed heavy-weight drug development programmes with annual budgets of more than $100 million USD. All clinical trials and submission activities in Europe, US, Japan, and China were completed ahead of aggressive targets and within budget.- Created, maintained, and monitored integrated programme plans using MS Project and Gantt Charts; monitored programme deliverables and reported variance in budget and timelines.- Developed a Team Tool to simplify the process of on-boarding new members; contribution was recognised as Project Management Best Practice, demonstrating project management excellence. Show less

Led the European regulatory strategy and interactions with regulatory agencies of the breast cancer indication of a blockbuster oncology biologics product.- Successfully led cross-functional project teams to prepare multiple high-quality regulatory submissions, such as applications for a major indication extension and various technical changes, ahead of project timelines.- Collaborated closely with alliance partner, participated in Alliance Steering Committee as regulatory… Show more Led the European regulatory strategy and interactions with regulatory agencies of the breast cancer indication of a blockbuster oncology biologics product.- Successfully led cross-functional project teams to prepare multiple high-quality regulatory submissions, such as applications for a major indication extension and various technical changes, ahead of project timelines.- Collaborated closely with alliance partner, participated in Alliance Steering Committee as regulatory submission lead.- Played key role in departmental initiatives and knowledge sharing, providing strategic guidance on seeking Scientific Advice during the drug development process. Show less

Managed multiple heavy-weight global regulatory projects in various therapeutic areas (e.g. haematology, oncology, bone metabolism, arthritis and pain), including orphan drugs. Achieving optimal development, regulatory filings and approvals of NDA’s and MAA’s with favourable labels. - Received Novartis President’s Award in 2004 and the Global Pharma Team Honourable Mentions in 2005 for outstanding teamwork in accelerating clinical trial timelines for early stage compound.- Received… Show more Managed multiple heavy-weight global regulatory projects in various therapeutic areas (e.g. haematology, oncology, bone metabolism, arthritis and pain), including orphan drugs. Achieving optimal development, regulatory filings and approvals of NDA’s and MAA’s with favourable labels. - Received Novartis President’s Award in 2004 and the Global Pharma Team Honourable Mentions in 2005 for outstanding teamwork in accelerating clinical trial timelines for early stage compound.- Received Business Excellence Award in 2001 for timely and quality review of promotional activities.- Completed an international assignment in Sales and Marketing at the Novartis affiliate in Hong Kong. Supported launch of a new oncology product and acted as sales representative for various cardiovascular products. Show less